1 |
Sheikh, M. S. and Fornace, A. J., JR. (2000) Role of p53 family members in apoptosis. J. Cell. Physiol. 182, 171-181.
DOI
ScienceOn
|
2 |
Siddiqui, I. A., Malik, A., Adhami, V. M., Asim, M., Hafeez, B. B., Sarfaraz, S. and Mukhtar, H. (2008) Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene 27, 2055-2063.
DOI
|
3 |
Unger, M. A., Chou, H. P., Thorsen, T., Scherer, A. and Quake, S. R. (2000) Monolithic microfabricated valves and pumps by multilayer soft lithography. Science 288, 113-116.
DOI
|
4 |
Wang, Z., Kim, M.-C., Marquez, M. and Thorsen, T. (2007) High-density microfl uidic arrays for cell cytotoxicity analysis. Lab. Chip 7, 740-745.
DOI
ScienceOn
|
5 |
Whitesides, G. M., Ostuni, E., Takayama, S., Jiang, X. and Ingber, D. E. (2001) Soft lithography in biology and biochemistry. Annu. Rev. Biomed. Eng. 3, 335-373.
DOI
ScienceOn
|
6 |
Wilken, R., Veena, M. S., Wang, M. B. and Srivatsan, E. S. (2011) Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol. Cancer 10, 12.
DOI
|
7 |
Zhang, L. and Fang, B. (2005) Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Ther. 12, 228-237.
DOI
ScienceOn
|
8 |
Kelley, S. K. and Ashkenazi, A. (2004) Targeting death receptors in can cer with Apo2L/TRAIL. Curr. Opin. Pharmacol. 4, 333-339.
DOI
ScienceOn
|
9 |
Kim, J., Hegde, M. and Jayaraman, A. (2010a) Co-culture of epithelial cells and bacteria for investigating host-pathogen interactions. Lab. Chip 10, 43-50.
DOI
|
10 |
Kim, J., Hegde, M. and Jayaraman, A. (2010b) Microfl uidic co-culture of epithelial cells and bacteria for investigating soluble signal-mediated interactions. J. Vis. Exp.
|
11 |
Kim, J., Hegde, M., Kim, S. H., Wood, T. K. and Jayaraman, A. (2012a) A microfluidic device for high throughput bacterial biofilm studies. Lab. Chip 12, 1157-1163.
DOI
ScienceOn
|
12 |
Kim, J., Taylor, D., Agrawal, N., Wang, H., Kim, H., Han, A., Rege, K. and Jayaraman, A. (2012b) A programmable microfluidic cell array for combinatorial drug screening. Lab. Chip 12, 1813-1822.
DOI
ScienceOn
|
13 |
Lai, H. and Folch, A. (2011) Design and dynamic characterization of "single-stroke" peristaltic PDMS micropumps. Lab. Chip 11, 336-342.
DOI
|
14 |
Lee, P. J., Hung, P. J., Rao, V. M. and Lee, L. P. (2006) Nanoliter scale microbioreactor array for quantitative cell biology. Biotechnol. Bioeng. 94, 5-14.
DOI
ScienceOn
|
15 |
Li, N., Hsu, C. H. and Folch, A. (2005) Parallel mixing of photolithographically defi ned nanoliter volumes using elastomeric microvalve arrays. Electrophoresis 26, 3758-3764.
DOI
|
16 |
Neils, C., Tyree, Z., Finlayson, B. and Folch, A. (2004) Combinatorial mi xing of microfluidic streams. Lab. Chip 4, 342-350.
DOI
|
17 |
Shankar, S., Singh, T. R. and Srivastava, R. K. (2004) Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms. Prostate 61, 35-49.
DOI
ScienceOn
|
18 |
Ohtsuka, T., Ryu, H., Minamishima, Y. A., Ryo, A. and Lee, S. W. (2003) Modulation of p53 and p73 levels by cyclin G: implication of a negative feedback regulation. Oncogene 22, 1678-1687.
DOI
ScienceOn
|
19 |
Shankar, S., Chen, X. and Srivastava, R. K. (2005) Effects of sequential treatments with chemotherapeutic drugs followed by TRAIL on prostate cancer in vitro and in vivo. Prostate 62, 165-186.
DOI
|
20 |
Shankar, S., Siddiqui, I. and Srivastava, R. K. (2007) Molecular mechani sms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells. Mol. Cell. Biochem. 304, 273-285.
DOI
ScienceOn
|
21 |
Beltran, H., Beer, T. M., Carducci, M. A., De Bono, J., Gleave, M., Hussain, M., Kelly, W. K., Saad, F., Sternberg, C., Tagawa, S. T. and Tannock, I. F. (2011) New therapies for castration-resistant prostate cancer: efficacy and safety. Eur. Urol. 60, 279-290.
DOI
|
22 |
Bouralexis, S., Findlay, D. M. and Evdokiou, A. (2005) Death to the bad guys: targeting cancer via Apo2L/TRAIL. Apoptosis 10, 35-51.
DOI
|
23 |
Deeb, D., Gao, X., Jiang, H., Divine, G., Dulchavsky, S. A. and Gautam, S. C. (2006) Vaccination with leukemia-loaded dendritic cells eradicates residual disease and prevent relapse. J. Exp. Ther. Oncol. 5, 183-193.
|
24 |
Graf, N. J. and Bowser, M. T. (2013) Effect of cross sectional geometry on PDMS micro peristaltic pump performance: comparison of SU-8 replica molding vs. micro injection molding. Analyst 138, 5791-5800.
DOI
|
25 |
Deeb, D., Jiang, H., Gao, X., Al-Holou, S., Danyluk, A. L., Dulchavsky, S. A. and Gautam, S. C. (2007) Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nu clear factor-kappaB via inhibition of the prosurvival Akt signaling pathway. J. Pharmacol. Exp. Ther. 321, 616-625.
DOI
ScienceOn
|
26 |
Deeb, D., Jiang, H., Gao, X., Hafner, M. S., Wong, H., Divine, G., Chapman, R. A., Dulchavsky, S. A. and Gautam, S. C. (2004) Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation. Mol. Cancer. Ther. 3, 803-812.
|
27 |
Garstecki, P., Fuerstman, M. J., Stone, H. A. and Whitesides, G. M. (2006) Formation of droplets and bubbles in a microfl uidic T-junction-scaling and mechanism of break-up. Lab. Chip 6, 437-446.
DOI
ScienceOn
|
28 |
Heger, M., Van Golen, R. F., Broekgaarden, M. and Michel, M. C. (2014) The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer. Pharmacol. Rev. 66, 222-307.
|
29 |
Hung, P. J., Lee, P. J., Sabounchi, P., Aghdam, N., Lin, R. and Lee, L. P. (2005a) A novel high aspect ratio microfluidic design to provide a stable and uniform microenvironment for cell growth in a high throughput mammalian cell culture array. Lab. Chip 5, 44-48.
DOI
ScienceOn
|
30 |
Hung, P. J., Lee, P. J., Sabounchi, P., Lin, R. and Lee, L. P. (2005b) Continuous perfusion microfluidic cell culture array for high-through put cell-based assays. Biotechnol. Bioeng. 89, 1-8.
DOI
ScienceOn
|
31 |
Adam, V., Ekblad, M., Sweeney, K., Muller, H., Busch, K. H., Johnsen, C. T., Kang, N. R., Lemoine, N. R. and Hallden, G. (2012) Synergistic and selective cancer cell killing mediated by the oncolytic adenoviral mutant addeltadelta and dietary phytochemicals in prostate cancer models. Hum. Gene Ther. 23, 1003-1015.
DOI
ScienceOn
|
32 |
Aggarwal, B. B., Kumar, A. and Bharti, A. C. (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 23, 363-398.
|
33 |
Amin, A. R., Kucuk, O., Khuri, F. R. and Shin, D. M. (2009) Perspectives for cancer prevention with natural compounds. J. Clin. Oncol. 27, 2712-2725.
DOI
ScienceOn
|
34 |
Barua, S., Linton, R. S., Gamboa, J., Banerjee, I., Yarmush, M. L. and Rege, K. (2010) Lytic peptide-mediated sensitization of TRAILresistant prostate cancer cells to death receptor agonists. Cancer Lett. 293, 240-253.
DOI
|
35 |
Simons, J. W., Mikhak, B., Chang, J. F., Demarzo, A. M., Carducci, M. A., Lim, M., Weber, C. E., Baccala, A. A., Goemann, M. A., Clift, S. M., Ando, D. G., Levitsky, H. I., Cohen, L. K., Sanda, M. G., Mulligan, R. C., Partin, A. W., Carter, H. B., Piantadosi, S., Marshall, F. F. amd Nelson, W. G. (1999) Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocytemacrophage colony-stimulating factor using ex vivo gene transfer. Cancer Res. 59, 5160-5168.
|